Zobrazeno 1 - 10
of 126
pro vyhledávání: '"B. Overdijk"'
Autor:
Hilma J. van der Horst, Simone C. Oostindie, Saskia. A. G. M. Cillessen, Anne T. Gelderloos, Marije B. Overdijk, Inger. S. Nijhof, Sonja Zweegman, Martine E. D. Chamuleau, Esther C. W. Breij, Tuna Mutis
Publikováno v:
HemaSphere, Vol 5, Iss 1, p e504 (2021)
Externí odkaz:
https://doaj.org/article/6d390e89e66241889326e117c149837e
Autor:
Esther C.W. Breij, Rob N. de Jong, Paul W.H.I. Parren, Janine Schuurman, Ulf Forssmann, Andreas Lingnau, Richard G. Hibbert, Naomi Hoevenaars, Bart de Jong, Thessa Kroes, Boris S. Vuillermoz, Claudine Vermot-Desroches, Antonio Ortiz Buijsse, Frank J. Beurskens, Kristin Strumane, Marije B. Overdijk
Supplemental Tables Supplemental Figures Supplemental Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fc0742629adc9c9f5ee0bce476596b4
https://doi.org/10.1158/1535-7163.22520991.v1
https://doi.org/10.1158/1535-7163.22520991.v1
Autor:
Esther C.W. Breij, Rob N. de Jong, Paul W.H.I. Parren, Janine Schuurman, Ulf Forssmann, Andreas Lingnau, Richard G. Hibbert, Naomi Hoevenaars, Bart de Jong, Thessa Kroes, Boris S. Vuillermoz, Claudine Vermot-Desroches, Antonio Ortiz Buijsse, Frank J. Beurskens, Kristin Strumane, Marije B. Overdijk
Higher-order death receptor 5 (DR5) clustering can induce tumor cell death; however, therapeutic compounds targeting DR5 have achieved limited clinical efficacy. We describe HexaBody-DR5/DR5, an equimolar mixture of two DR5-specific IgG1 antibodies w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2f853ed6f8830a1d4904eeb661710e2
https://doi.org/10.1158/1535-7163.c.6542862.v1
https://doi.org/10.1158/1535-7163.c.6542862.v1
Autor:
Steven T. Pals, Marcel Spaargaren, Roel Nusse, Derk ten Berge, Marije B. Overdijk, Esther J.M. Schilder-Tol, Monique E.C.M. Oud, Richard W.J. Groen
Supplementary Table 3 from Illegitimate WNT Pathway Activation by β-Catenin Mutation or Autocrine Stimulation in T-Cell Malignancies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e9aede58952770765a84d30b8e20298
https://doi.org/10.1158/0008-5472.22377129
https://doi.org/10.1158/0008-5472.22377129
Autor:
Steven T. Pals, Marcel Spaargaren, Roel Nusse, Derk ten Berge, Marije B. Overdijk, Esther J.M. Schilder-Tol, Monique E.C.M. Oud, Richard W.J. Groen
Supplementary Table 1 from Illegitimate WNT Pathway Activation by β-Catenin Mutation or Autocrine Stimulation in T-Cell Malignancies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33fdd1ff7064047901b607fd4f992b65
https://doi.org/10.1158/0008-5472.22377135
https://doi.org/10.1158/0008-5472.22377135
Autor:
Steven T. Pals, Marcel Spaargaren, Roel Nusse, Derk ten Berge, Marije B. Overdijk, Esther J.M. Schilder-Tol, Monique E.C.M. Oud, Richard W.J. Groen
Supplementary Table 2 from Illegitimate WNT Pathway Activation by β-Catenin Mutation or Autocrine Stimulation in T-Cell Malignancies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e30d09f2553206510ebab116adccbfb
https://doi.org/10.1158/0008-5472.22377132.v1
https://doi.org/10.1158/0008-5472.22377132.v1
Autor:
Sonja Zweegman, Anne T. Gelderloos, Esther C.W. Breij, Inger S. Nijhof, Tuna Mutis, Hilma J. van der Horst, Marije B. Overdijk, Martine E D Chamuleau
Publikováno v:
van der Horst, H J, Gelderloos, A T, Chamuleau, M E D, Breij, E C W, Zweegman, S, Nijhof, I S, Overdijk, M B & Mutis, T 2021, ' Potent preclinical activity of HexaBody-DR5/DR5 in relapsed and/or refractory multiple myeloma ', Blood, vol. 5, no. 8, pp. 2165-2172 . https://doi.org/10.1182/BLOODADVANCES.2020003731
Blood Adv
Blood, 5(8), 2165-2172. American Society of Hematology
Blood Adv
Blood, 5(8), 2165-2172. American Society of Hematology
Apoptosis induction by death receptor (DR)-specific agonistic antibodies is a potentially effective antitumor therapy. Nonetheless, to date, all conventional DR-targeting antibodies that induce apoptosis via FcγR-dependent DR clustering failed to sh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ebbd19120d9f0155a225c20e7061bf0
http://www.scopus.com/inward/record.url?scp=85106295701&partnerID=8YFLogxK
http://www.scopus.com/inward/record.url?scp=85106295701&partnerID=8YFLogxK
Autor:
Mandy Gruijs, Rens Braster, Marije B. Overdijk, Tessa Hellingman, Sandra Verploegen, Rianne Korthouwer, Berend J. van der Wilk, Paul W. H. I. Parren, Hans J. van der Vliet, Marijn Bögels, Marjolein van Egmond
Publikováno v:
Journal of Oncology
Journal of Oncology, 2022. HINDAWI LTD
Journal of oncology, 2022:3577928. Hindawi Publishing Corporation
Gruijs, M, Braster, R, Overdijk, M B, Hellingman, T, Verploegen, S, Korthouwer, R, van der Wilk, B J, Parren, P W H I, van der Vliet, H J, Bögels, M & van Egmond, M 2022, ' Epidermal Growth Factor Receptor as Target for Perioperative Elimination of Circulating Colorectal Cancer Cells ', Journal of oncology, vol. 2022, 3577928, pp. 3577928 . https://doi.org/10.1155/2022/3577928
Journal of Oncology, Vol 2022 (2022)
Journal of Oncology, 2022. HINDAWI LTD
Journal of oncology, 2022:3577928. Hindawi Publishing Corporation
Gruijs, M, Braster, R, Overdijk, M B, Hellingman, T, Verploegen, S, Korthouwer, R, van der Wilk, B J, Parren, P W H I, van der Vliet, H J, Bögels, M & van Egmond, M 2022, ' Epidermal Growth Factor Receptor as Target for Perioperative Elimination of Circulating Colorectal Cancer Cells ', Journal of oncology, vol. 2022, 3577928, pp. 3577928 . https://doi.org/10.1155/2022/3577928
Journal of Oncology, Vol 2022 (2022)
Surgical resection of the tumor is the primary treatment of colorectal cancer patients. However, we previously demonstrated that abdominal surgery promotes the adherence of circulating tumor cells (CTC) in the liver and subsequent liver metastasis de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f52bf81969dc25572fa78d545f08db7c
http://europepmc.org/articles/PMC8759909
http://europepmc.org/articles/PMC8759909
Autor:
Stefanie Derer, Sven Berger, Martin Schlaeth, Tanja Schneider-Merck, Katja Klausz, Stefan Lohse, Marije B. Overdijk, Michael Dechant, Christian Kellner, Iris Nagelmeier, Andreas H. Scheel, Jeroen J. Lammerts van Bueren, Jan G.J. van de Winkel, Paul W.H.I. Parren, Matthias Peipp, Thomas Valerius
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 14, Iss 3, Pp 190-205 (2012)
Oncogenic KRAS mutations in colorectal cancer (CRC) are associated with lack of benefit from epidermal growth factor receptor (EGFR)-directed antibody (Ab) therapy. However, the mechanisms by which constitutively activated KRAS (KRASG12V) impairs eff
Externí odkaz:
https://doaj.org/article/f35805a210d2477089c2536154f9e1ad
Autor:
Esther C.W. Breij, Hilma J. van der Horst, Simone C. Oostindie, Sonja Zweegman, Martine E D Chamuleau, Inger S. Nijhof, Marije B. Overdijk, Saskia A. G. M. Cillessen, Tuna Mutis, Anne T. Gelderloos
Publikováno v:
HemaSphere
HemaSphere, 5(1). Wolters Kluwer Health
HemaSphere, Vol 5, Iss 1, p e504 (2021)
Van Der Horst, H J, Oostindie, S C, Cillessen, S A G M, Gelderloos, A T, Overdijk, M B, Nijhof, I S, Zweegman, S, Chamuleau, M E D, Breij, E C W & Mutis, T 2021, ' Potent Preclinical Efficacy of DuoHexaBody-CD37 in B-Cell Malignancies ', HemaSphere, vol. 5, no. 1, pp. E504 . https://doi.org/10.1097/HS9.0000000000000504
HemaSphere, 5(1). Wolters Kluwer Health
HemaSphere, Vol 5, Iss 1, p e504 (2021)
Van Der Horst, H J, Oostindie, S C, Cillessen, S A G M, Gelderloos, A T, Overdijk, M B, Nijhof, I S, Zweegman, S, Chamuleau, M E D, Breij, E C W & Mutis, T 2021, ' Potent Preclinical Efficacy of DuoHexaBody-CD37 in B-Cell Malignancies ', HemaSphere, vol. 5, no. 1, pp. E504 . https://doi.org/10.1097/HS9.0000000000000504
Supplemental Digital Content is available in the text.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f889d7418b64dcdd8f08c84d9cb32d23
http://europepmc.org/articles/PMC7732266
http://europepmc.org/articles/PMC7732266